|Whether you want someone to handle your clinical study in its entirety, assist with specific parts of it or outsource a certain staff, you can choose City as dependable partner.|
PRICING & MARKET ACCESS
We offer our clients portfolio optimization and product-level access to European countries. Our experts provide our clients with the necessary details to have a clear picture of the likely therapeutic and reimbursement landscape of the market in which the product will eventually be launched, to enable them to make informed decisions to optimize the treatment potential.
Our Health Economics expert will work with you to design and delivery of health economics strategies to support national access in the target country. Will develeop and perform Health Technology Assessment submissions and will create market access and health economics value demonstration tools to support the field team. Pleaes contact us with your inquiry.
PATIENT REPORTED OUTCOMES
Please contact us with requests for Patient Reported Outcomes (PROs). The instruments used to measure PROs may be generic in that they can be used in any population, regardless of disease or intervention. Most common expample is the Short-Form health surveys. Also there are specific instruments that could be used on a particular disease, population, or condition. While there are concerns that specific instruments may overlook the global well-being of a patient, they are often more sensitive to changes that are secondary to the disease or its treatment.
Please contact us if you need to register a new drug to be marketed outside of the country of manufacture. We will have our experts to notify the authority(-ies) of your company intention for submition of the marketing authorization application package (where applicable), prepare the actual package, selection of rapporteur/co-rapporteur (if required), and assist with product naming as necessary.